Update on rituximab.
作者信息
Eisenberg R
机构信息
University of Pennsylvania, PA, USA.
出版信息
Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv55-7. doi: 10.1136/ard.2005.042648.
Abstract
摘要
相似文献
1
Update on rituximab.利妥昔单抗最新进展
Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv55-7. doi: 10.1136/ard.2005.042648.
2
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.评论：类风湿关节炎中，类风湿因子阳性而非抗环瓜氨酸肽抗体阳性、较低的残疾程度以及较少的抗 TNF 药物治疗失败与对利妥昔单抗的反应相关。
Rheumatology (Oxford). 2010 Sep;49(9):1795-6; author reply 1796-7. doi: 10.1093/rheumatology/keq141. Epub 2010 May 19.
3
4
The updated guidelines on the use of rituximab in rheumatoid arthritis.利妥昔单抗在类风湿关节炎中应用的更新指南。
Rheumatology (Oxford). 2011 Dec;50(12):2153-4. doi: 10.1093/rheumatology/ker149. Epub 2011 May 4.
5
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience.类风湿关节炎的B细胞疗法：利妥昔单抗（抗CD20）的应用经验
Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii55-9. doi: 10.1136/ard.62.suppl_2.ii55.
6
[Proposal for biologic drugs therapy in rheumatoid arthritis].[类风湿关节炎生物药物治疗方案]
Reumatizam. 2010;57(1):29-35.
7
New and promising treatments for rheumatoid arthritis.类风湿关节炎的新型且有前景的治疗方法。
Am J Orthop (Belle Mead NJ). 2007 Jul;36(7 Suppl):18-23.
8
Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis.类风湿关节炎首支肿瘤坏死因子-α拮抗剂治疗失败后的策略。
Autoimmun Rev. 2010 Jun;9(8):574-82. doi: 10.1016/j.autrev.2010.04.002. Epub 2010 Apr 28.
9
Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.B细胞清除疗法对肿瘤坏死因子α拮抗剂治疗无效的类风湿关节炎患者的疗效：一项开放标签观察性研究。
Ann Rheum Dis. 2006 Sep;65(9):1255-7. doi: 10.1136/ard.2005.051169. Epub 2006 Mar 15.
10
Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab.使用利妥昔单抗治疗的类风湿关节炎患者接种流感疫苗后血清学反应不佳。
Ann Rheum Dis. 2007 Oct;66(10):1402-3. doi: 10.1136/ard.2007.071878.
引用本文的文献
1
Evolution of Anti-citrullinated Protein Antibodies in Rheumatoid Arthritis Patients Under Disease-Modifying Therapy: A Prospective Cohort Study.病情缓解治疗下类风湿关节炎患者抗瓜氨酸化蛋白抗体的演变：一项前瞻性队列研究
Cureus. 2025 Mar 7;17(3):e80217. doi: 10.7759/cureus.80217. eCollection 2025 Mar.
2
The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium.不断扩展的抗中性粒细胞胞浆抗体相关性血管炎治疗手段
Drugs. 2025 Mar;85(3):325-341. doi: 10.1007/s40265-024-02143-z. Epub 2025 Feb 19.
3
Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists.抗CD20治疗背景下新型冠状病毒肺炎疫苗的接种时机：肾脏病学家指南
Kidney Int Rep. 2021 May;6(5):1197-1199. doi: 10.1016/j.ekir.2021.03.876. Epub 2021 Apr 1.
4
Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product.利妥昔单抗生物类似药 CT-P10 与参比制剂的分析相似性评估。
MAbs. 2018 Apr;10(3):380-396. doi: 10.1080/19420862.2018.1433976. Epub 2018 Mar 6.
5
Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient.一名弥漫性大B细胞淋巴瘤患者的脑弓形虫病
Radiol Oncol. 2016 Feb 16;50(1):87-93. doi: 10.1515/raon-2014-0042. eCollection 2016 Mar 1.
6
Recent advances in the field of anti-cancer immunotherapy.抗癌免疫疗法领域的最新进展。
BBA Clin. 2015 Apr 18;3:280-8. doi: 10.1016/j.bbacli.2015.04.001. eCollection 2015 Jun.
7
Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎的经验。
Ther Adv Musculoskelet Dis. 2014 Apr;6(2):58-74. doi: 10.1177/1759720X13516239.
8
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.肌痛性脑脊髓炎/慢性疲劳综合征和播散性脑脊髓炎/多发性硬化症在表型和神经免疫特征方面表现出显著的相似性。
BMC Med. 2013 Sep 17;11:205. doi: 10.1186/1741-7015-11-205.
9
The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).自身免疫在肌痛性脑脊髓炎/慢性疲劳综合征（ME/cfs）中日益凸显的作用。
Mol Neurobiol. 2014 Apr;49(2):741-56. doi: 10.1007/s12035-013-8553-0. Epub 2013 Sep 26.
10
Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.B细胞定向治疗的转化性小型综述系列：自身免疫性疾病的B细胞定向治疗
Clin Exp Immunol. 2009 Aug;157(2):181-90. doi: 10.1111/j.1365-2249.2009.03977.x.
本文引用的文献
1
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic.肿瘤坏死因子阻断剂与结核病：新药照亮旧话题。
Rheumatology (Oxford). 2005 Jun;44(6):714-20. doi: 10.1093/rheumatology/keh567. Epub 2005 Mar 1.
2
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.利妥昔单抗对原发性进行性多发性硬化症患者外周血和脑脊液B细胞的影响。
Arch Neurol. 2005 Feb;62(2):258-64. doi: 10.1001/archneur.62.2.258.
3
Rituximab in the treatment of dermatomyositis: an open-label pilot study.利妥昔单抗治疗皮肌炎：一项开放标签的试点研究。
Arthritis Rheum. 2005 Feb;52(2):601-7. doi: 10.1002/art.20849.
4
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.11例难治性抗中性粒细胞胞浆抗体相关性血管炎患者通过B淋巴细胞清除实现缓解。
Arthritis Rheum. 2005 Jan;52(1):262-8. doi: 10.1002/art.20718.
5
Treatment of SLE with anti-CD20 monoclonal antibody.用抗CD20单克隆抗体治疗系统性红斑狼疮。
Curr Dir Autoimmun. 2005;8:193-205. doi: 10.1159/000082104.
6
Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.利妥昔单抗可改善人类系统性红斑狼疮的外周B细胞异常。
Arthritis Rheum. 2004 Nov;50(11):3580-90. doi: 10.1002/art.20592.
7
B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.B细胞清除作为系统性红斑狼疮的一种新疗法：利妥昔单抗的I/II期剂量递增试验
Arthritis Rheum. 2004 Aug;50(8):2580-9. doi: 10.1002/art.20430.
8
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.利妥昔单抗靶向B细胞治疗对类风湿关节炎患者的疗效。
N Engl J Med. 2004 Jun 17;350(25):2572-81. doi: 10.1056/NEJMoa032534.
9
SLE - Rituximab in lupus.系统性红斑狼疮——利妥昔单抗治疗狼疮
Arthritis Res Ther. 2003;5(4):157-9. doi: 10.1186/ar759. Epub 2003 Apr 15.
10
Safety of rituximab in lymphoma patients with hepatitis B or hepatitis C virus infection.
Hematol J. 2003;4(2):159-62. doi: 10.1038/sj.thj.6200243.
Zotero 插件